Clinical Trials on Carcinoma, Non-Small Cell Lung in Canada

Total 1468 results

National Cancer Institute (NCI)

Not yet recruiting

Biomarkers in Predicting Treatment Response in Samples From Patients With Early-Stage Non-Small Cell Lung Cancer Previously Treated With Adjuvant Chemotherapy

Stage IIIA Non-small Cell Lung Cancer | Stage IA Non-small Cell Lung Cancer | Stage IB Non-small Cell Lung Cancer | Stage IIA Non-small Cell Lung Cancer | Stage IIB Non-small Cell Lung Cancer

Canada
Ontario Clinical Oncology Group (OCOG)
Ontario Ministry of Health and Long Term Care

Completed

Positron Emission Tomography (PET) Imaging in Stage III Non-small Cell Lung Cancer (PET START Trial)

Non-Small-Cell Lung Carcinoma

Canada
National Cancer Institute (NCI)

Active, not recruiting

Testing the Combination of MLN0128 (TAK-228) and AZD9291 in Advanced EGFR (Epidermal Growth Factor Receptor) Mutation Positive Non-small Cell Lung Cancer

Metastatic Lung Non-Small Cell Carcinoma | Stage IIIA Lung Non-Small Cell Cancer AJCC v7 | Recurrent Lung Non-Small Cell Carcinoma | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage IV Lung Non-Small Cell Cancer AJCC v7 | Stage III Lung Non-Small Cell Cancer AJCC v7

United States, Canada
University Health Network, Toronto

Recruiting

Study of Binimetinib in Combination With Pembrolizumab in Advanced Non-Small Cell Lung Cancer

Non-small Cell Carcinoma

Canada
Peter MacCallum Cancer Centre, Australia

Completed

Sequencing of Stereotactic Ablative Body Radiotherapy in Combination With PD-1 Blockade Using Pembrolizumab in Metastatic Non-Small Cell Lung Carcinoma (SABRseq)

Non-small Cell Lung Cancer

Australia, Canada
Juravinski Cancer Center

Unknown

Locally Invasive NSCLC Treated With NEo-Adjuvant Stereotactic Body RadioTherapy and REsection (LINNEARRE-I)

Carcinoma | Non-Small-Cell Lung Cancer

Canada
University Health Network, Toronto

Active, not recruiting

Observing Patients With Palliative Asymptomatic Centrally Located Advanced Non-small Cell Lung Carcinoma (NSCLC)

Non-small Cell Lung Carcinoma

Canada
Lawson Health Research Institute

Recruiting

Model to Predict pCR and IrAEs in Early Stage Non-small Cell Lung Cancer (Pre-PLaN)

Non-small Cell Lung Cancer Stage IB (Resectable) | Non-small Cell Lung Cancer Stage II (Resectable) | Non-small Cell Lung Cancer Stage ⅢA (Resectable)

Canada
Ontario Clinical Oncology Group (OCOG)
Ontario Ministry of Health and Long Term Care

Completed

PET Imaging in Potentially Surgically Resectable Non-small Cell Lung Cancers (ELPET)

Non-small-cell Lung Carcinoma

Canada
St. Joseph's Healthcare Hamilton
Health Sciences Centre, Winnipeg, Manitoba; Centre hospitalier de l'Université... and other collaborators

Completed

The Canada Lymph Node Score Project: A Crossover Trial (CLNS)

Lung Cancer | Non Small Cell Lung Cancer | Non-small Cell Lung Cancer Stage I | Non-small Cell Lung Cancer Stage II

Canada
Centre hospitalier de l'Université de Montréal...

Recruiting

Dietary Intervention for NSCLC Patients Treated With ICI

Non Small Cell Lung Cancer

Canada
AHS Cancer Control Alberta

Recruiting

A Nutritional Supplement to Support People With Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

Canada
University Health Network, Toronto

Completed

Stereotactic Body Radiotherapy (RT) for Non-Small Cell Lung Cancer

Non Small Cell Lung Cancer

Canada
CancerCare Manitoba

Terminated

Neoadjuvant Finasteride for Patients With Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

Canada
University Health Network, Toronto
Hoffmann-La Roche

Completed

Surgery for Early Lung Cancer With Preoperative Erlotinib (Tarceva): A Clinical Phase II Trial (SELECT) (SELECT)

Non Small Cell Lung Cancer

Canada
Uman Pharma
DSM Nutritional Products, Inc.; MDEIE Ministry, Québec Government; INRS-Institut...

Completed

MTD Determination, Safety and Efficacy of the Decitabine-Genistein Drug Combination in Advanced Solid Tumors and Non-Small Cell Lung Cancer

Non Small Cell Lung Cancer

Canada
Lawson Health Research Institute
London Regional Cancer Program, Canada

Terminated

Shrinking Target Adaptive Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer

Non Small Cell Lung Cancer

Canada
Alberta Health services

Completed

CT-Based Versus Conventional Simulation for Palliative Radiotherapy of Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer

Canada
University Health Network, Toronto

Completed

Endobronchial Ultrasound vs Mediastinoscopy in NSCLC

Non-small Cell Lung Cancer

Canada
University of Saskatchewan

Completed

Alternating Cycles of Carboplatin/Gemcitabine and Carboplatin/Taxol for Advanced Stage NSCLC

Non Small Cell Lung Cancer

Canada
Lawson Health Research Institute

Terminated

Functional Lung Avoidance for Individualized Radiotherapy (FLAIR): A Randomized, Double-Blind Clinical Trial (FLAIR)

Non-small Cell Lung Cancer

Canada
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Surgery and/or Radiation Therapy or Standard Therapy and/or Clinical Observation in Treating Patients With Previously Treated Stage IV Non-small Cell Lung Cancer

Recurrent Lung Non-Small Cell Carcinoma | Stage IV Non-Small Cell Lung Cancer AJCC v7

United States, Canada
University Health Network, Toronto
Pfizer

Recruiting

Study of Crizotinib for ROS1 and MET Activated Lung Cancer

Non-squamous Non-small-cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | ROS1 Gene Rearrangement | MET Activating Mutation | MET Amplification

Canada
Lawson Health Research Institute

Recruiting

Detection of Circulating Tumor DNA After Stereotactic Ablative Radiotherapy in Patients With Unbiopsied Lung Tumors (SABR-DETECT)

Non Small Cell Lung Cancer

Canada
University Health Network, Toronto
Bristol-Myers Squibb

Recruiting

Study of Nivolumab-Ipilimumab and cfDNA in Lung Cancer (ATLAS)

Non Small Cell Lung Cancer

Canada
Lawson Health Research Institute

Active, not recruiting

A Phase II Trial Measuring the Integration of Stereotactic Radiotherapy Plus Surgery in Early Non-Small Cell Lung Cancer

Non Small Cell Lung Cancer

Canada
University Health Network, Toronto

Completed

Phase II Lung Metcore - Preoperative Metformin for Lung Cancer (Metcore)

Lung Cancer | Non Small Cell Lung Cancer

Canada
Centre de Recherche de l'Institut Universitaire...

Unknown

Characterization of Peripheral Muscle Function in Patients With Non-small-cell Lung Cancer

Non-Small-cell Lung Cancer

Canada
Centre hospitalier de l'Université de Montréal...
Centre de Recherche du Centre Hospitalier de l'Université de Montréal

Completed

Pre-Operative Assessment of Chest Wall Invasion in NSCLC Using Pre-Operative, Surgeon Performed Ultrasound (CT0010)

Non Small Cell Lung Cancer

Canada
Ontario Clinical Oncology Group (OCOG)
Roche Pharma AG

Completed

Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation Therapy for Non-small Cell Lung Cancer (PEARL)

Non-small Cell Lung Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Phase I/II Study of Fractionated Stereotactic Radiotherapy for Early Stage Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer

Canada
University of British Columbia

Unknown

Detection of Early Lung Cancer by Serum Protein Expression Profiling

Non-small Cell Lung Cancer

Canada
Hoffmann-La Roche

Completed

A Feasibility Trial of Avastin (Bevacizumab) in Combination With Concomitant Chemoradiation (Cisplatin and Vinorelbine) in Patients With Locally Advanced Non-Squamous Non-Small Cell Lung Cancer.

Non-Squamous Non-Small Cell Lung Cancer

Canada
Canadian Cancer Trials Group
AstraZeneca

Completed

Study of Selumetinib in Patients With Previously Treated or Untreated Advanced/Metastatic NSCLC

Non Small Cell Lung Cancer

Canada
National Cancer Institute (NCI)

Completed

Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery

Stage IIIA Non-small Cell Lung Cancer | Squamous Cell Lung Cancer | Adenocarcinoma of the Lung | Bronchoalveolar Cell Lung Cancer | Large Cell Lung Cancer | Adenosquamous Cell Lung Cancer | Stage IB Non-small Cell Lung Cancer | Stage IIA Non-small Cell Lung Cancer | Stage IIB Non-small Cell Lung Cancer

Canada
National Cancer Institute (NCI)

Completed

AZD0530 to Treat Recurrent Stage IIIB/IV NSCLC Previously Treated With Combination Chemotherapy

Stage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer

Canada
PeriPharm
Jewish General Hospital; Personalized Medicine Partnership for Cancer

Terminated

Study to Evaluate Real-world Pharmacoeconomics of Crizotinib in NSCLC Patients

Non-small Cell Lung Cancer Metastatic

Canada
AstraZeneca

Completed

Epidemiological Study to Describe Non Small Cell Lung Cancer Clinical Management Patterns in MENA. Lung-EPICLIN/ Gulf (Lung-EPICLIN/G)

Non Small Cells Lung Cancer

Qatar, Bahrain, United Arab Emirates
Lawson Health Research Institute

Active, not recruiting

SUNSET: SBRT for Ultra-central NSCLC- a Safety and Efficacy Trial

Non Small Cell Lung Cancer

Canada
University Health Network, Toronto

Completed

Piloting the Feasibility of FLT-PET/CT Non-Small Cell Lung Cancer Managed With SBRT (SBRT FLT-PET)

Non Small Cell Lung Cancer (NSCLC)

Canada
University Health Network, Toronto
AstraZeneca

Withdrawn

A Multi-Cancer, Multi-State, Platform Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Pancreatic Adenocarcinoma, Non-Small Cell Lung Cancer and Squamous Cell Carcinoma of the Head and Neck to Correlate Clinical, Molecular and Immunologic Parameters With DNA Methylation (DOME)

Squamous Cell Carcinoma of Head and Neck | Non-small Cell Lung Cancer | Pancreatic Ductal Adenocarcinoma

Canada
University Health Network, Toronto

Completed

Achieving Value in Cancer Diagnostics: Blood Versus Tissue Molecular Profiling - a Prospective Canadian Study (VALUE)

Non-small Cell Lung Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Terminated

A Phase I Dose Escalation Study of Erlotinib in Combination With Theophylline

Non-small Cell Lung Cancer | Advanced Solid Malignancies

Canada
University Health Network, Toronto
Mount Sinai Hospital, Canada

Completed

Computer-Generated Quality of Life Assessment Program for Advanced Non-Small Cell Lung Cancer Patients (LUNL2) (LUNL2)

Non Small Cell Lung Cancer

Canada
Washington University School of Medicine
National Cancer Institute (NCI)

Recruiting

Surgery Versus Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer (SORT)

Non Small Cell Lung Cancer | Non-small Cell Lung Cancer

United States, Canada
Centre de Recherche de l'Institut Universitaire...
CHU de Quebec-Universite Laval

Withdrawn

Surgery Versus Stereotactic Body Radiation Therapy for Stage up to IA2 (T1a or T1b) Non-small Cell Lung Cancer (RAXSIA)

Surgery | Non-small Cell Lung Cancer Stage I | Stereotactic Body Radiation Therapy

Canada
AstraZeneca

Completed

RELEVANCE - RWE Study in Unresectable Non-Small Cell Lung Cancer (Stage III) in Canada (RELEVANCE)

Non-small Cell Lung Cancer

Canada
Jewish General Hospital
Pfizer; PeriPharm; Quebec Clinical Research Organization in Cancer; Personalized...

Unknown

Study to Evaluate Resistance Mechanisms and Real-world Pharmacoeconomics of Crizotinib in NSCLC Patients

Non-small Cell Lung Cancer Metastatic

Canada
Hoffmann-La Roche

Terminated

A Study Evaluating RO5479599 in Combination With Carboplatin and Paclitaxel in Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) of Squamous Histology

Squamous Non-Small Cell Lung Cancer

Canada, Spain, Denmark
British Columbia Cancer Agency

Recruiting

CSF Analysis in EGFR Mutant Non-Small Cell Lung Cancer With Leptomeningeal Disease

Non Small Cell Lung Cancer | EGFR Activating Mutation | Leptomeningeal Metastasis

Canada

Clinical Trials on Carcinoma, Non-Small Cell Lung in Canada

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Trinidad & Tobago

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations